Logo

EC Clears Thermo Fisher Buy of Phadia

Aug 19, 2011

NEW YORK (GenomeWeb News) – The European Commission has cleared Thermo Fisher Scientific's $3.5 billion purchase of Phadia, the EC said today.

The deal was earlier cleared by the US Federal Trade Commission, and during Thermo Fisher's recent second-quarter earnings conference call, CEO Marc Casper moved up the anticipated close of the transaction to the third quarter from the fourth quarter.

Thermo Fisher said earlier this week it had issued $2.1 billion in senior notes, partly to fund the acquisition.

Filed under

Diagnostics
ABRF
Thermo Fisher Scientific
Breaking News
The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.